As the tumourigenic process in MLH1 epimutation follows the same process as Lynch syndrome resulting from germline MMR pathogenic variants, cancer diagnosis age in MLH1 epimutation is thought to be similar to Lynch syndrome and younger than cases with somatic MLH1 hypermethylation. This evidence concerns the gene MLH1 and cancer.